Tharimmune (THAR) Stock Chart & Stock Price History $1.52 -0.02 (-0.98%) As of 03:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tharimmune Stock Price Performance The Tharimmune (THAR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 51.44%, with a year-to-date return of -25.37%. In the past month, the stock has decreased 8.73%, reflecting recent market activity. As of the latest close, Tharimmune traded at $1.53 with a market cap of $4.07 million and volume of 35,893 shares. Receive THAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-10.36%1 Month Performance-8.73%3 Month Performance+28.83%Year-To-Date Performance-25.37%1 Year Performance-51.44% THAR Stock Chart for Friday, July, 25, 2025 THAR Chart by TradingView Tharimmune Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/24/2025$1.66$1.53-7.83%$1.65$1.5035,893 shs$4.07 million07/23/2025$1.62$1.66+2.47%$1.66$1.6119,303 shs$4.42 million07/22/2025$1.66$1.62-2.64%$1.68$1.6210,013 shs$4.31 million07/21/2025$1.69$1.66-1.54%$1.70$1.6583,820 shs$4.43 million07/18/2025$1.65$1.69+2.42%$1.75$1.6770,254 shs$4.50 million07/17/2025$1.63$1.65+1.23%$1.74$1.6342,694 shs$4.39 million07/16/2025$1.68$1.63-2.98%$1.69$1.6145,535 shs$4.34 million07/15/2025$1.69$1.68-0.59%$1.82$1.60123,534 shs$4.47 million07/14/2025$1.73$1.69-2.31%$1.81$1.65109,430 shs$4.50 million07/11/2025$1.77$1.73-2.26%$1.80$1.7118,511 shs$4.60 million Get the Latest News and Ratings for THAR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. 07/10/2025$1.76$1.77+0.57%$1.79$1.7024,034 shs$4.71 million07/09/2025$1.76$1.76$1.88$1.7314,131 shs$4.68 million07/08/2025$1.69$1.76+4.14%$1.85$1.709,300 shs$4.68 million07/07/2025$1.84$1.69-7.95%$1.86$1.6075,268 shs$4.50 million07/04/2025$1.84$1.84$1.87$1.7312,482 shs$4.88 million07/03/2025$1.82$1.84+0.88%$1.87$1.7312,482 shs$4.88 million07/02/2025$1.78$1.82+2.25%$1.85$1.7517,040 shs$4.84 million07/01/2025$1.94$1.78-8.26%$1.96$1.7351,247 shs$4.74 million06/30/2025$1.80$1.94+7.64%$1.95$1.7968,397 shs$5.16 million06/27/2025$1.76$1.80+2.41%$1.85$1.7241,400 shs$4.80 million06/26/2025$1.66$1.76+6.03%$1.78$1.6152,769 shs$4.68 million06/25/2025$1.54$1.66+8.02%$1.75$1.53111,245 shs$4.42 million06/24/2025$1.31$1.54+17.31%$1.54$1.3874,562 shs$4.09 million Related Companies Lipocine Stock Chart Citius Pharmaceuticals Stock Chart Gelteq Stock Chart Edesa Biotech Stock Chart Allarity Therapeutics Stock Chart CASI Pharmaceuticals Stock Chart Carisma Therapeutics Stock Chart Cocrystal Pharma Stock Chart Ernexa Therapeutics Stock Chart Mannatech Stock Chart Receive THAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:THAR) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredThe big winner of Crypto week?It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption. With Bit...Weiss Ratings | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tharimmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tharimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free THAR Stock Alerts